NCT02009137View on ClinicalTrials.gov

Efficacy and Safety Study of EVERA to Augment Small Breast

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

August 31, 2014

Conditions
Atrophy of Breast
Interventions
DEVICE

EVERA

EVERA apply for 12 weeks

DEVICE

ESTES

ESTES apply for 12 weeks

Trial Locations (1)

463-707

Seoul National Univ. Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02009137 - Efficacy and Safety Study of EVERA to Augment Small Breast | Biotech Hunter | Biotech Hunter